- Phare
 - Validé par KD/KO
 
Anticorps Recombinant de lapin anti-Beta galactosidase
Beta galactosidase Recombinant Antibody for WB, IF/ICC, FC (Intra), ELISA
Hôte / Isotype
Lapin / IgG
Réactivité testée
Humain
Applications
WB, IF/ICC, FC (Intra), ELISA
Conjugaison
Non conjugué
CloneNo.
240788F1
N° de cat : 83706-6-RR
Synonymes
Galerie de données de validation
Applications testées
| Résultats positifs en WB | cellules A549, cellules HEK-293, cellules HepG2, cellules K-562, cellules SH-SY5Y | 
| Résultats positifs en IF/ICC | cellules HepG2, | 
| Résultats positifs en FC (Intra) | cellules A549, | 
Dilution recommandée
| Application | Dilution | 
|---|---|
| Western Blot (WB) | WB : 1:5000-1:50000 | 
| Immunofluorescence (IF)/ICC | IF/ICC : 1:125-1:500 | 
| Flow Cytometry (FC) (INTRA) | FC (INTRA) : 0.25 ug per 10^6 cells in a 100 µl suspension | 
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, check data in validation data gallery | |
Informations sur le produit
83706-6-RR cible Beta galactosidase dans les applications de WB, IF/ICC, FC (Intra), ELISA et montre une réactivité avec des échantillons Humain
| Réactivité | Humain | 
| Hôte / Isotype | Lapin / IgG | 
| Clonalité | Recombinant | 
| Type | Anticorps | 
| Immunogène | Beta galactosidase Protéine recombinante Ag7792 | 
| Nom complet | galactosidase, beta 1 | 
| Masse moléculaire calculée | 76 kDa | 
| Poids moléculaire observé | 62-67 kDa | 
| Numéro d’acquisition GenBank | BC007493 | 
| Symbole du gène | GLB1/Beta-galactosidase | 
| Identification du gène (NCBI) | 2720 | 
| Conjugaison | Non conjugué | 
| Forme | Liquide | 
| Méthode de purification | Protein A purfication | 
| Tampon de stockage | PBS with 0.02% sodium azide and 50% glycerol | 
| Conditions de stockage | Stocker à -20°C. Stable pendant un an après l'expédition. L'aliquotage n'est pas nécessaire pour le stockage à -20oC Les 20ul contiennent 0,1% de BSA. | 
Informations générales
GLB1(Beta-galactosidase) is also named as ELNR1 or Lactase. It cleaves beta-linked terminal galactosyl residues from gangliosides, glycoproteins, and glycosaminoglycans. This protein is identical to the elastin-binding protein (EBP), a major component of the nonintegrin cell surface receptor complex expressed in fibroblasts, smooth muscle cells, chondroblasts, leukocytes, and certain cancer cell types. Defects in GLB1 are the cause of GM1-gangliosidosis type 1 (GM1G1), GM1-gangliosidosis type 2 (GM1G2), GM1-gangliosidosis type 3 (GM1G3) and mucopolysaccharidosis type 4B (MPS4B). GBL1 is synthesized as an 85-kDa precursor that is C-terminally processed into a 64-66 kDa mature form and the released ~20-kDa proteolytic fragment was thought to be degraded (PMID: 10744681). The MW of GLB1 after glycosylation is 100-120 kd. GLB1 is prone to produce homodimers (220-240 kd) and higher multimers (PMID: 3926488). GLB1 has 3 isoforms with MW of 76 kDa, 73 kda, and 61 kDa.
Protocole
| Product Specific Protocols | |
|---|---|
| WB protocol for Beta galactosidase antibody 83706-6-RR | Download protocol | 
| IF protocol for Beta galactosidase antibody 83706-6-RR | Download protocol | 
| FC protocol for Beta galactosidase antibody 83706-6-RR | Download protocol | 
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols | 





